The US Food and Drug Administration (FDA) has released a report citing several unsanitary practices including peeling paint, shoddy clean-ups and poorly trained staff at the Baltimore plant owned by Emergent Biosolutions (EBS), which is producing Johnson & Johnson鈥檚 (J&J) Covid-19 vaccine.

This report confirmed media intelligence that the vaccine made at the Emergent plant was contaminated with the material used to make AstraZeneca鈥檚 Covid-19 vaccine, claims Reuters.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

According to the FDA鈥檚 request, Emergent will pause the new production of vaccines and work on rectifying issues pointed out on the vaccine quality produced in this plant.

The vaccines, which are already produced, will be carefully analysed to guarantee their quality prior to their distribution for vaccination.

The FDA noted that this action report is not linked to its ongoing evaluation by the agency and US Centers for Disease Control and Prevention (CDC) of rare blood clot reports linked to the vaccine.

At present, a plant in the Netherlands is producing the key drug substance used in this vaccine.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don鈥檛 let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Meanwhile, J&J has reported primary data from the Phase III ENSEMBLE clinical trial that showed its single-dose Covid-19 vaccine provided protection against hospitalisation and death 28 days after vaccination.

The trial met all primary and key secondary endpoints.

Data showed that, despite emerging SARS-CoV-2 variant concerns, the vaccine’s efficacy was consistent against symptomatic infection.

Johnson & Johnson chief scientific officer and executive committee vice-chairman Paul Stoffels said: 鈥淭his comprehensive evidence demonstrates that Johnson & Johnson鈥檚 single-shot Covid-19 vaccine offers protection and prevents hospitalisation and death, including in countries where viral variants are highly prevalent.鈥

色界吧 Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The 色界吧 Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don鈥檛 miss your chance to stand out鈥攕ubmit your entry today!

Nominate Now